| Cell cycle |
1.73 |
3.11e-1 |
110/124 (88.71%) |
PLK1;CDKN1B;CDC20;...
|
| Carbohydrate digestion and absorption |
1.67 |
3.29e-1 |
37/47 (78.72%) |
SLC37A4;MGAM;PLCB1;...
|
| Propanoate metabolism |
1.57 |
4.85e-1 |
30/34 (88.24%) |
SUCLA2;ABAT;DLD;...
|
| Homologous recombination |
1.57 |
3.64e-1 |
35/41 (85.37%) |
BRCA1;RPA3;MRE11;...
|
| Fanconi anemia pathway |
1.57 |
2.98e-1 |
36/54 (66.67%) |
BRCA1;RPA3;RAD51C;...
|
| Butanoate metabolism |
1.56 |
2.59e-1 |
23/28 (82.14%) |
BDH2;ABAT;ACAT1;...
|
| Diabetic cardiomyopathy |
1.54 |
2.88e-1 |
162/203 (79.8%) |
MMP9;PLCB1;PIK3R1;...
|
| Glyoxylate and dicarboxylate metabolism |
1.51 |
3.21e-1 |
23/30 (76.67%) |
DLD;ACAT1;GLDC;...
|
| DNA replication |
1.49 |
3.45e-1 |
34/36 (94.44%) |
PRIM1;RPA3;POLE2;...
|
| Aminoacyl-tRNA biosynthesis |
1.49 |
3.20e-1 |
15/66 (22.73%) |
IARS2;QRSL1;FARS2;...
|
| Sulfur relay system |
1.47 |
3.30e-1 |
5/8 (62.5%) |
TST;MPST;MOCS2;...
|
| Progesterone-mediated oocyte maturation |
1.46 |
3.21e-1 |
75/100 (75%) |
PLK1;MAD2L1;PIK3R1;...
|
| Fc epsilon RI signaling pathway |
1.45 |
3.10e-1 |
57/68 (83.82%) |
ALOX5;PIK3R1;MAPK1;...
|
| Fatty acid elongation |
1.44 |
3.21e-1 |
19/27 (70.37%) |
ACAA2;PPT1;TECR;...
|
| Leukocyte transendothelial migration |
1.42 |
3.37e-1 |
90/114 (78.95%) |
MMP9;MYL12B;PIK3R1;...
|
| Synthesis and degradation of ketone bodies |
1.42 |
3.17e-1 |
9/10 (90%) |
BDH2;ACAT1;OXCT1
|
| SNARE interactions in vesicular transport |
1.40 |
3.45e-1 |
19/33 (57.58%) |
BET1;STX8;STX3;...
|
| Glutamatergic synapse |
1.39 |
3.49e-1 |
97/114 (85.09%) |
GRIA2;PLCB1;GRIK2;...
|
| Renin-angiotensin system |
1.39 |
3.36e-1 |
20/23 (86.96%) |
ANPEP;MME;REN;...
|
| Neutrophil extracellular trap formation |
1.39 |
3.37e-1 |
101/189 (53.44%) |
PLCB1;PIK3R1;HAT1;...
|
| Oocyte meiosis |
1.38 |
3.55e-1 |
90/129 (69.77%) |
PLK1;CDC20;MAD2L1;...
|
| Glycosylphosphatidylinositol (GPI)-anchor biosynthesis |
1.37 |
3.51e-1 |
20/26 (76.92%) |
PIGC;PIGP;GPAA1;...
|
| Transcriptional misregulation in cancer |
1.36 |
3.50e-1 |
158/192 (82.29%) |
CDKN1B;DEFA4;MMP9;...
|
| Retrograde endocannabinoid signaling |
1.35 |
3.65e-1 |
118/148 (79.73%) |
GRIA2;PLCB1;NDUFA5;...
|
| TGF-beta signaling pathway |
1.35 |
3.62e-1 |
81/94 (86.17%) |
ID4;HAMP;IFNG;...
|
| Oxidative phosphorylation |
1.34 |
3.71e-1 |
93/133 (69.92%) |
NDUFA5;NDUFB3;SDHC;...
|
| Serotonergic synapse |
1.32 |
4.00e-1 |
97/114 (85.09%) |
ALOX5;PLCB1;MAPK1;...
|
| GnRH secretion |
1.29 |
4.68e-1 |
60/64 (93.75%) |
PLCB1;PIK3R1;MAPK1;...
|
| Long-term depression |
1.28 |
4.79e-1 |
55/60 (91.67%) |
GRIA2;PLCB1;MAPK1;...
|
| Taurine and hypotaurine metabolism |
1.28 |
4.67e-1 |
8/11 (72.73%) |
ADO;GAD1;CSAD;...
|
| beta-Alanine metabolism |
-1.41 |
2.29e-1 |
25/30 (83.33%) |
ALDH3B1;AOC2;ALDH9A1;...
|
| Nitrogen metabolism |
-1.43 |
1.96e-1 |
16/17 (94.12%) |
GLUL;CA4;CA9;...
|
| alpha-Linolenic acid metabolism |
-1.43 |
1.91e-1 |
17/25 (68%) |
PLA2G10;PLA2G2D;ACAA1;...
|
| Herpes simplex virus 1 infection |
-1.45 |
1.77e-1 |
165/498 (33.13%) |
HCFC2;DDX58;MTOR;...
|
| Endocytosis |
-1.46 |
1.70e-1 |
198/252 (78.57%) |
HGS;ARFGAP2;ACAP2;...
|
| Thyroid hormone synthesis |
-1.46 |
1.70e-1 |
66/75 (88%) |
PLCB4;CREB3;ALB;...
|
| Amino sugar and nucleotide sugar metabolism |
-1.47 |
1.61e-1 |
38/48 (79.17%) |
NANS;GFPT2;GMDS;...
|
| Bacterial invasion of epithelial cells |
-1.48 |
1.64e-1 |
59/77 (76.62%) |
SHC1;DOCK1;DNM1;...
|
| Autophagy |
-1.48 |
1.56e-1 |
113/169 (66.86%) |
DAPK3;HRAS;MTMR4;...
|
| Allograft rejection |
-1.49 |
1.58e-1 |
32/38 (84.21%) |
HLA-DOB;HLA-F;HLA-E;...
|
| Antigen processing and presentation |
-1.49 |
1.60e-1 |
60/78 (76.92%) |
CTSL;NFYA;CANX;...
|
| Phenylalanine metabolism |
-1.50 |
1.53e-1 |
14/17 (82.35%) |
HPD;ALDH3B1;AOC2;...
|
| Phagosome |
-1.50 |
1.60e-1 |
118/152 (77.63%) |
SEC61G;ATP6V0A4;CTSL;...
|
| Arachidonic acid metabolism |
-1.51 |
1.61e-1 |
48/61 (78.69%) |
PTGDS;PTGES3;PLA2G10;...
|
| Ascorbate and aldarate metabolism |
-1.52 |
1.59e-1 |
15/30 (50%) |
ALDH2;UGDH;ALDH3A2
|
| Vibrio cholerae infection |
-1.52 |
1.66e-1 |
44/50 (88%) |
PLCG2;KDELR3;ACTB;...
|
| ECM-receptor interaction |
-1.52 |
1.64e-1 |
80/88 (90.91%) |
ITGB6;COL4A6;LAMC3;...
|
| Epithelial cell signaling in Helicobacter pylori infect... |
-1.54 |
1.53e-1 |
62/70 (88.57%) |
CCL5;PLCG2;PAK1;...
|
| Viral myocarditis |
-1.54 |
1.60e-1 |
53/60 (88.33%) |
CYCS;CASP9;RAC3;...
|
| Mitophagy |
-1.54 |
1.72e-1 |
56/68 (82.35%) |
CSNK2B;MAPK9;USP8;...
|
| Graft-versus-host disease |
-1.55 |
1.83e-1 |
32/42 (76.19%) |
HLA-DOB;HLA-F;HLA-E;...
|
| Histidine metabolism |
-1.57 |
1.61e-1 |
16/22 (72.73%) |
MAOA;ALDH2;ALDH3A2;...
|
| Ferroptosis |
-1.58 |
1.61e-1 |
36/41 (87.8%) |
GCLC;TP53;FTL;...
|
| Basal cell carcinoma |
-1.60 |
1.65e-1 |
41/63 (65.08%) |
TCF7L1;TCF7;FZD7;...
|
| Viral protein interaction with cytokine and cytokine re... |
-1.60 |
1.85e-1 |
84/100 (84%) |
CXCL13;IL2RG;CCL17;...
|
| Autoimmune thyroid disease |
-1.62 |
1.69e-1 |
46/53 (86.79%) |
TSHR;HLA-DOB;TPO;...
|
| Glutathione metabolism |
-1.63 |
1.81e-1 |
43/57 (75.44%) |
GCLC;ODC1;IDH1;...
|
| Protein export |
-1.67 |
1.58e-1 |
17/23 (73.91%) |
SRPRB;SEC61G;SRP14;...
|
| Protein processing in endoplasmic reticulum |
-1.67 |
1.82e-1 |
127/171 (74.27%) |
GANAB;MOGS;SEC61G;...
|
| Collecting duct acid secretion |
-1.74 |
1.68e-1 |
22/27 (81.48%) |
ATP6V0A4;SLC4A1;ATP6V0E2;...
|
